10th April 2019
- 0 comments
Intermediate Capital Group’s Europe VII Fund has announced it has, in partnership with Mérieux Equity Partners and DOC Generici’s management team, agreed to invest in Doc Generici, one of Italy’s largest independent generic pharmaceutical companies - subject to antitrust approval.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.